Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Global Neurotech (GNT) Pharma and Toyota Tsush (TTC) have entered into a strategic alliance for further development of Neu2000 and AAD-2004 targeting CNS and inflammatory diseases.
Subscribe to our email newsletter
TTC will represent GNT exclusively in Japan in promoting its products and technologies in the area of new drug discovery for neurological and inflammatory diseases.
The alliance with GNT will allow TTC to provide customer-oriented business to Japanese pharmaceutical manufacturers through the domestic network, TTC said.
GNT Pharma CEO and R&D head Byoung Gwag said: "As TTC’s plan looks to expand its revenue related to non-automotive business, we are pleased to help it grow in the life sciences and healthcare business globally."